High-grade atrioventricular heart block (HGAVB) occurring as a manifestation of systemic lupus erythematosus is an exceedingly rare event. We describe a patient with HGAVB who had myositis and antibodies to nuclear RNP (previously associated with myocarditis). A review of the literature on HGAVB associated with systemic lupus erythematosus is also presented.Cardiovascular involvement occurs in the majority of patients with systemic lupus erythematosus (SLE). It is manifested most commonly by pericarditis, which has been reported in 12-100% of patients, and myocarditis, which is clinically apparent in < 10% of patients in most series. It has been recognized in autopsy series in >40% of subjects (1). Although the documented incidence of arrhythmias or conduction disturbance in SLE patients is seldom reported to be >lo%, one can reasonably suspect that the undocumented paroxysmal disturbances in cardiac rhythms are considerably more common (2).High-grade atrioventricular block (HGAVB) as a manifestation of SLE is an extremely rare event, being previously described in only 7 patients (2-7). Several investigators have reported first-or second- degree atrioventricular block in association with SLE (2,8,9). We describe an adult with SLE who developed HGAVB, which occurred in the setting of a putative drug reaction to trimethoprim/sulfamethoxazole (T/S); this patient also had myositis and antibodies to nuclear ribonucleoprotein (nRNP) (U1 RNP), which have been previously associated with myocarditis (10).
CASE REPORTThe patient, a 42-year-old black woman with SLE, was referred to The Johns Hopkins Hospital because of intermittent palpitations and dizziness. She had been well until 7 days before admission, at which time she began taking T/S for dysuria. Two days later, palpitations and dizziness began, and these symptoms continued to worsen until the time of admission. On the day prior to admission, the patient discontinued the T/S on her own.Seven years earlier, the patient had been diagnosed as having SLE. Her symptoms at that time were fatigue, periungual erythema, migratory polyarthritis, pleurisy, weakness, and Raynaud's phenomenon. There had been no evidence of sclerodactyly, puffy fingers, or telangiectasias. She was then leukopenic, antinuclear antibody (ANA) positive, and had myositis proven by biopsy. When corticosteroids were administered, her symptoms had resolved and her creatine kinase (CK) level had returned to normal. Prednisone therapy given at that time was gradually completely tapered and withdrawn. For the 2 years prior to the symptoms that brought her to our care, she enjoyed good health and was taking no medications. She denied having cardiac or pericardial symptoms, and previous results of electrocardiograms (EKGs) were